Mumbai, February 27, 2018: Pharma real Walks Shasun said it has chosen to dispatch the ‘over the counter’ form of ulcer medicate Ranitidine in 150 mg measurement in the US advertises quickly.
Steps Shasun is now a key player in the US Ranitidine showcase with 32 percent piece of the overall industry through its remedy form in 150 mg and 300 mg measurements.
The new dispatch will additionally fortify organization’s Ranitidine establishment.
As indicated by IRI information, the US OTC market for Ranitidine Tablets, which is the non specific type of the prominent brand Zantac, is around USD 200 million.
This is likewise the principal item endorsement from organization’s 50:50 JV with Vivimed Labs.
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…